Anaerobesystems
About Anaerobesystems
Anaerobesystems is a company was acquired by Biolog in February 2025. The company has 28 employees as of December 31, 2022.
- Employees 28 as on 31 Dec, 2022
-
Sectors
Chemicals & Materials
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Anaerobesystems
Unlock access to complete
Unlock access to complete
Funding Insights of Anaerobesystems
Detailed funding history for Anaerobesystems
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Anaerobesystems
Anaerobesystems has secured backing from 1 investor. Prominent investors backing the company include Biolog.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cell-based phenotyping technologies and assays are provided for microbial analysis.
|
Locked | Locked | Locked |
Investor details for Anaerobesystems
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Anaerobesystems
Investment portfolio details for Anaerobesystems
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Anaerobesystems
Detailed financials for Anaerobesystems
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Anaerobesystems Comparisons
Peer comparison for Anaerobesystems
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Anaerobesystems
Detailed competitors of Anaerobesystems
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Anaerobesystems
Complete news archive for Anaerobesystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anaerobesystems
As of Dec 31, 2022, the latest employee count at Anaerobesystems is 28.
Anaerobic chambers in various sizes and configurations are produced for the cultivation of anaerobic organisms. Pre-reduced, anaerobically sterilized culture media, available in plated and broth forms, are manufactured under strict anaerobic conditions to prevent oxygen exposure. These products support clinical isolation, identification of anaerobes, microbiome research, and related applications. Training courses in anaerobic bacteriology are also provided by the company in the microbiology sector.
Anaerobesystems has 1 investor. Key investors include Biolog.